Skip to main content
. Author manuscript; available in PMC: 2020 Jun 3.
Published in final edited form as: Mol Pharm. 2019 May 14;16(6):2364–2375. doi: 10.1021/acs.molpharmaceut.8b01296

Figure 4.

Figure 4.

Oxycodone-specific antibody titers and DLS. (A) DLS of sKLH and OXY-sKLH batch 1 and 11. (B) Male Holtzman rats (n = 3–17/group) were immunized by IM injection with 60 μg of OXY-sKLH with 90 μg of alum on day 0. Serum was collected on day 7 and oxycodone-specific antibody titers were measured. Data are mean ± SD (C–E) SEC analysis performed on sKLH and OXY-sKLH (batch 1 and 11).

*p < 0.05 compared to batch 1.